Clint Hermes draws on his experience as general counsel at two teaching hospitals to advise medical centers, universities, and life sciences companies on regulatory, accreditation, and corporate governance matters. In addition, Clint also offers clients practical advice and insights on biomedical research and international projects.
A small sample of Clint’s broad-ranging work with these clients includes:
- Meeting with the Secretary of Health and Human Services and other Cabinet secretaries, members of the U.S. House and Senate, foreign health and finance ministers, and the World Health Organization to discuss strategic agreements and client policy priorities.
- Negotiating academic and research affiliation agreements.
- Designing sophisticated enterprise risk management programs.
- Presenting to boards of directors on governance, compliance, government enforcement, litigation, and strategic transactions.
- Developing and overseeing organizational conflict of interest programs.
- Preparing for Joint Commission, AAHRPP, and ACGME reviews.
- Setting up research consortia.
- Establishing healthcare and humanitarian programs overseas.
Clint has particularly extensive experience advising on the regulation of human and animal research, clinical trial registration and transparency, conflicts of interest, federal grants, biospecimens, data privacy, expanded access to investigational products, research collaborations, and the developing national security regulation of research. His work on behalf of research institutions and life sciences companies has taken him throughout Africa, Asia, the Middle East, and South America. He has served on many Conflict of Interest Committees and Institutional Review Boards (IRBs) in the United States and abroad, including as Vice Chair of a Harvard-affiliated IRB and of a biobank IRB abroad, and as health and science policy advisor to a foreign country, where laws that he drafted are in effect today.
Clint Hermes draws on his experience as general counsel at two teaching hospitals to advise medical centers, universities, and life sciences companies on regulatory, accreditation, and corporate governance matters. In addition, Clint also offers clients practical advice and insights on biomedical research and international projects.
A small sample of Clint’s broad-ranging work with these clients includes:
- Meeting with the Secretary of Health and Human Services and other Cabinet secretaries, members of the U.S. House and Senate, foreign health and finance ministers, and the World Health Organization to discuss strategic agreements and client policy priorities.
- Negotiating academic and research affiliation agreements.
- Designing sophisticated enterprise risk management programs.
- Presenting to boards of directors on governance, compliance, government enforcement, litigation, and strategic transactions.
- Developing and overseeing organizational conflict of interest programs.
- Preparing for Joint Commission, AAHRPP, and ACGME reviews.
- Setting up research consortia.
- Establishing healthcare and humanitarian programs overseas.
Clint has particularly extensive experience advising on the regulation of human and animal research, clinical trial registration and transparency, conflicts of interest, federal grants, biospecimens, data privacy, expanded access to investigational products, research collaborations, and the developing national security regulation of research. His work on behalf of research institutions and life sciences companies has taken him throughout Africa, Asia, the Middle East, and South America. He has served on many Conflict of Interest Committees and Institutional Review Boards (IRBs) in the United States and abroad, including as Vice Chair of a Harvard-affiliated IRB and of a biobank IRB abroad, and as health and science policy advisor to a foreign country, where laws that he drafted are in effect today.
Clint has authored numerous articles and book chapters (including in peer-reviewed journals and a widely-used textbook) in the areas of international health projects and biomedical research and has been quoted in publications such as MIT’s Technology Review, STAT News, Bloomberg Law, Law360, Modern Healthcare, and Canada’s Globe and Mail. He currently serves as co-editor of the Bass, Berry & Sims bi-monthly email, Grand Rounds – a quick-hitting overview of recent news and insights and the impact of these developments on AMC institutions.
Before joining Bass, Berry & Sims, Clint experienced first-hand the unique needs of institutions with large research programs and a global reach. He served as Senior Vice President and Chief Legal Officer at St. Jude Children’s Research Hospital and then served as General Counsel and Board Secretary of Sidra Medicine, a women’s and children’s teaching hospital in Doha, Qatar, affiliated with Cornell University. In those roles, Clint led legal affairs, technology transfer/licensing, ethics and compliance, board management, and an IRB.
